[Prognostic factors in the drug therapy of metastasizing breast cancer].
作者信息
Mörz R, Schemper M, Bettelheim P, Breyer S, Francesconi M, Graninger W, Jakesz R, Kolb R, Micksche M, Rainer H, Reiner G, Moser K
出版信息
Acta Med Austriaca Suppl. 1979;6:319-22.
PMID:299219
Abstract
175 patients with metastatic breast cancer, treated with chemotherapy, were analyzed retrospectively to identify the characteristics of prognostic importance in predicting response to chemotherapy and survival from onset of the chemotherapy. The most significant factors were the sites of metastatic disease and an estimate of the total extent of disease.
摘要
相似文献
1
[Prognostic factors in the drug therapy of metastasizing breast cancer].
Acta Med Austriaca Suppl. 1979;6:319-22.
2
Prognostic factors in metastatic breast cancer treated with combination chemotherapy.
Cancer Res. 1979 May;39(5):1552-62.
3
4
Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
N Engl J Med. 1978 Dec 14;299(24):1330-4. doi: 10.1056/NEJM197812142992403.
5
Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
Anticancer Res. 1993 Jul-Aug;13(4):1235-7.
6
Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer.
Cancer Treat Rep. 1984 Apr;68(4):573-6.
7
Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
Eur J Cancer (1965). 1980;Suppl 1:141-6.
8
[Value of hormone therapy in metastasizing breast cancer].
Wien Med Wochenschr. 1985 Dec 31;135(23-24):602-7.
9
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
N Engl J Med. 1978 Jun 1;298(22):1223-8. doi: 10.1056/NEJM197806012982203.
10
[Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
Wien Klin Wochenschr. 1981 Mar 20;93(6):205-7.
Zotero 插件